Clinical trial Recruiting at 1 site Observational Ages Any age to 18

Pediatric Epilepsies: How the illness progresses and affects thinking over time

Official title: Natural History and Prognosis of Pediatric Epilepsies With Different Etiology: Long-term Study

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07588971 · Data updated 2026-11-12

This study will watch children and teens with epilepsy to see how cognitive function changes and what factors predict those changes.

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment2300 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Rome)
StatusRecruiting
StartedOctober 26, 2021
Main results expectedJanuary 1, 2027
Study endsJune 1, 2027
Registry record updatedMay 15, 2026
Trial IDNCT07588971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents with onset of epilepsy between 0 and 18 years who are seen at Fondazione Policlinico Gemelli or referred during follow-up.

Probably not a fit

Patients with non-epileptic conditions or those lacking detailed follow-up data may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows patients with pediatric epilepsy seen at a single Italian center to describe how cognition evolves over time. Researchers will look for clinical and instrumental factors that predict cognitive function and its variation. The goal is to identify pathways and determinants that influence prognosis in pediatric epilepsies. There are no experimental interventions in this study; it relies on routine clinical data and follow-up. Results may help guide expectations and management for affected families.

Why it matters

Potential benefit: If successful, the study could improve understanding of cognitive outcomes and guide personalized care for children with epilepsy.

How similar studies have gone: Past observational work in pediatric epilepsy has shown that cognitive trajectories vary and may be predicted by clinical and developmental factors.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients seen at the Children's Neuropsychiatry of the Fondazione Policlinico Gemelli IRCCS (UOS Diagnosis and Treatment of Drug-Resistant Epilepsies, Day Hospital or inpatient setting at the Department of Children's Neuropsychiatry) with onset of first seizure between the ages of 0 and 18 years and subsequent diagnostic confirmation of epilepsy (2 or more unprovoked seizures at least 24 hours apart or definite epilepsy syndrome, with diagnostic confirmation by the child neuropsychiatrist).
* Patients already followed at Child Neuropsychiatry with a diagnosis of epilepsy with age of onset between 0 and 18 years.
* Patients referred to our Center during follow-up with a diagnosis of epilepsy with age of onset between 0 and 18 years.

Exclusion Criteria:

* Patients with unconfirmed diagnosis of epilepsy after the first critical episode.
* Patients from other Centers, for whom the history, clinical and instrumental data are not sufficiently detailed and in accordance with the methodologies followed at our Center.
* Patients with follow-up \< 2 years.
* Patients for whom study consent is not provided.

Where it's running

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Rome, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.